Blog Article

Reserve a few minutes each day to immerse yourself in science with content we've curated just for you. Each week we're highlighting informative videos, blogs, and products designed to help your COVID-19 research.

Check out our newly released Recombinant Human ACE2 protein. SARS-CoV-2 recognizes and binds to the ACE2 receptor to gain entry into host cells, making it an important research target.

 

WATCH: Introduction to Single Cell Proteogenomics Applications using TotalSeq™ Antibodies
(Approx. 2 minutes)

 

Watch this overview of proteogenomics to understand how our TotalSeq™ oligo-conjugated reagents enable simultaneous analysis of proteins and RNA.

 

View Now

 

---

 

 

WATCH: Overview of the TotalSeq™ Workflow
(Approx. 2 minutes)

 

In this video, walk through the single cell sequencing workflow and see how you can incorporate our TotalSeq™ reagents into commonly used workflows to generate proteomics data.

 

View Now

 

---

 

 

WATCH: Multimodal Techniques for High Content and High Throughput Cellular Phenotyping
(Approx. 1 hour)

 

Hear from Peter Smibert, Ph.D., of the New York Genome Center as he describes CITE-seq and other related technologies, how they compare to other single cell detection methods, and how they can lead to novel biological insights.

 

View Now

 

---

 

 

READ: Interferons During SARS-CoV-2 Infection
(Approx. 5 minutes)

 

In our weekly blog post, we'll explore the interferon (IFN) response during SARS-CoV-2 infection. This blog will summarize recent research using transcriptome and single cell analysis to examine the IFN response in COVID-19 patients and the effects of IFN-based treatment.

 

Read Now

 

---

 

 

ENGAGE: Win One of Our Puzzles

 

End your week by participating in one of our contests on Facebook, Twitter, or Instagram for a 500 or 1000 piece puzzle. Click on the social media icons below to make the social distancing experience a little easier.

 

Engage

 

---

 

 

BioLegend Tools Support SARS-COV-2 Research

 

BioLegend is ready to collaborate with your organization. Please tell us how we can support your work.

 

Explore